Clinical trial
The Effects of Intermittent Theta-burst Stimulation on Cognitive Function in Patients With Mild Cognitive Impairment and Mild Alzheimer's Disease and the Role of Brain-Derived Neurotrophic Factor
NCT06670820 is registered in ClinicalTrials.gov with National Defense Medical Center, Taiwan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effects of Intermittent Theta-burst Stimulation on Cognitive Function in Patients With Mild Cognitive Impairment and Mild Alzheimer's Disease and the Role of Brain-Derived Neurotrophic Factor
- Lead sponsor
- National Defense Medical Center, Taiwan
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- October 31, 2024
- Completion date
- December 31, 2028
- Enrollment
- 80 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
mild alzheimer disease, mild cognitive impairment (mci)